Skip to search formSkip to main contentSkip to account menu

AP 21967

Known as: AP-21967, AP21967 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Sirolimus
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Protein‐Protein Interaction Mapping by 2C‐BioID
Protein‐protein interactions (PPIs) add an essential layer of complexity to the information encoded by the genome. Modulation of… 
2018
2018
Synthetic splitting receptor-based controllable switch to improve the safety of EGFRvIII+ CAR-T cells for immunotherapy of glioblastoma
// Yan Zheng 1, * , Xiu-Ling Li 1, * , Xiang-Dong Sun 1 , Bing-Yong Zhang 1 , Puja Gupta 2 , Albert J Wong 2 , Tian-Fang Li 3 and… 
2017
2017
Blockade of Y177 and Nuclear Translocation of Bcr-Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells
The gradual emerging of resistance to imatinib urgently calls for the development of new therapy for chronic myeloid leukemia… 
2017
2017
Abstract 1708: Effective and reversible control of anti-tumor activityin vivowith a drug-regulated CAR T cell platform (DARIC)
Redirecting T cells against tumors by introducing antigen-specific chimeric antigen receptors (CAR) has shown promising clinical… 
2014
2014
The specific and rapid labeling of cell surface proteins with recombinant FKBP-fused fluorescent proteins
2009
2009
Quantification of Nuclear Protein Transport using Induced Heterodimerization
Trafficking of proteins between the cytoplasm and nucleus occurs exclusively across the nuclear pore complex of eucaryotic cells… 
2006
2006
Use of a stringent dimerizer-regulated gene expression system for controlled BMP2 delivery.
2006
2006
Gene therapy of ovarian cancer with IFN-α-producing fibroblasts: comparison of constitutive and inducible vectors
Ovarian cancer represents a malignancy suitable for cell and gene therapy approaches owing to its containment within the… 
2002
2002
A system for small-molecule control of conditionally replication-competent adenoviral vectors.
Replication-competent adenoviral vectors are potentially far more efficient than replication-defective vectors. However, for… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)